XBiotech Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $-33.2M | $-52.8M | $-37.5M | $-21.7M | $-9.9M |
| Depreciation & Amortization | — | — | — | — | — |
| Depreciation | $1.5M | $698.0K | $699.0K | $664.0K | $784.0K |
| Amortization | — | — | — | — | — |
| Stock-Based Compensation | $1.8M | $5.6M | $4.4M | $7.0M | $739.0K |
| Net Cash from Operating Activities | $-33.6M | $-46.0M | $-33.3M | $-11.7M | $-8.9M |
| Investing Activities | |||||
| Capital Expenditures | $1.4M | $4.7M | $2.3M | $1.4M | $59.0K |
| Business Acquisitions | — | — | — | — | — |
| Net Cash from Investing Activities | $-1.4M | $-13.9M | $-10.4M | $-1.4M | $-59.0K |
| Financing Activities | |||||
| Dividends Paid | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — |
| Net Cash from Financing Activities | $33.3M | $2.9M | $77.5M | $63.2M | $12.0M |
| Net Change in Cash | $-2.6M | $-56.7M | $33.7M | $50.1M | $3.1M |
| Free Cash Flow | $-35.1M | $-50.8M | $-35.6M | $-13.1M | $-9.0M |